文献速递冠心病

基于MAUDE数据库的导管导向肺栓塞介入器械不良事件分析

Catheter‐Directed Interventional Devices for Pulmonary Embolism: A Maude Database Analysis of Adverse Events
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-10-21

本研究利用FDA MAUDE数据库,分析三种FDA批准的导管导向肺栓塞治疗平台(EKOSONIC、INDIGO、FlowTriever)的不良事件报告。共纳入389份肺栓塞相关报告,其中76例死亡、133例损伤、180例器械故障。结果显示INDIGO大孔抽吸导管存在肺动脉穿孔相关信号,EKOSONIC存在颅内出血相关信号,死亡报告自2023年起增加。

要点

  • INDIGO大孔抽吸导管死亡报告中多数涉及穿孔、咯血、心脏压塞或外渗相关患者问题代码。
  • EKOSONIC相关报告中需警惕溶栓相关出血,包括颅内或脑出血。
  • 缺乏操作分母,无法推断发生率和因果关系,需持续上市后监测。

核心结论

  • MAUDE报告显示不同器械存在特异性安全信号:INDIGO大孔抽吸导管与肺动脉穿孔相关,EKOSONIC与颅内出血相关。
  • 死亡报告自2023年起随机械取栓术应用扩大而增加。
  • 缺乏操作分母,无法推断发生率和因果关系,结果支持操作者警觉、审慎选择患者及持续上市后监测。

研究设计与样本

  • 利用FDA MAUDE数据库,下载三种FDA批准的导管导向肺栓塞平台(EKOSONIC、INDIGO、FlowTriever)自各自肺栓塞适应证获批年份(分别为2008、2015、2018年)至2026年3月的医疗器械报告。
  • 通过文本筛选保留肺栓塞特异性报告,按制造商、事件类型(死亡、损伤、故障)、器械问题和患者问题进行分类,并按日历年评估趋势。
  • 共2528份报告中389份为肺栓塞特异性报告,时间跨度为2009年至2026年1月。

主要发现

  • 389份肺栓塞特异性报告中,INDIGO 228份(58.6%),EKOSONIC 149份(38.3%),FlowTriever 12份(3.1%)。
  • 事件类型分布:76例死亡(19.5%),133例损伤(34.2%),180例器械故障(46.3%)。
  • 年度死亡报告数:2023年15例,2024年13例,2025年8例,2026年1月3例。
  • 47例INDIGO死亡中,28例(59.6%)涉及Lightning/Flash大孔导管,36例(76.6%)带有穿孔、咯血、心脏压塞或外渗相关患者问题代码。
  • 分离导丝断裂/折断是INDIGO最主要的器械故障模式。

临床怎么用

  • 使用INDIGO大孔抽吸导管时需警惕肺动脉穿孔、咯血、心脏压塞和外渗风险。
  • 使用EKOSONIC时需关注溶栓相关出血,特别是颅内出血风险。
  • 机械取栓术应用扩大背景下,应加强操作者培训、审慎选择患者并持续监测安全性。

局限性

  • MAUDE为被动报告数据库,存在漏报和报告偏倚,无法据此推断发生率。
  • 缺乏操作总例数作为分母,无法计算发生率或推断因果关系。
  • FlowTriever相关肺栓塞特异性报告仅12份,数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background Catheter-directed therapies for acute pulmonary embolism (PE) are being adopted rapidly, yet real-world safety data remain limited. Aims To characterize adverse events, device failure patterns, and mortality signals for three FDA-cleared catheter-directed PE platforms (EKOSONIC, INDIGO, and FlowTriever) using the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Methods Medical device reports (MDRs) were downloaded from each device's PE clearance (2008, 2015, and 2018, respectively) through March 2026 and filtered by text to retain PE-specific reports. Reports were classified by manufacturer, event type (death, injury, malfunction), device problem, and patient problem, and trends were assessed by calendar year. Results Of 2528 reports, 389 were PE-specific (INDIGO 228 [58.6%], EKOSONIC 149 [38.3%], FlowTriever 12 [3.1%]), spanning 2009 to January 2026. There were 76 deaths (19.5%), 133 injuries (34.2%), and 180 malfunctions (46.3%). Annual death reports rose from 2023 (15 in 2023, 13 in 2024, 8 in 2025, and 3 in January 2026). Among 47 INDIGO deaths, 28 (59.6%) involved Lightning/Flash large-bore catheters, and 36 (76.6%) carried a perforation-, hemoptysis-, tamponade-, or extravasation-related patient problem code. Separator wire break/fracture was the leading INDIGO device failure. EKOSONIC reports showed thrombolytic-related bleeding, including intracranial or cerebral hemorrhage in 12 reports (8.1%). Conclusions MAUDE reports reveal distinct device-specific safety signals: pulmonary artery perforation with large-bore INDIGO aspiration catheters, and intracranial hemorrhage with EKOSONIC. Death reports increased from 2023 as mechanical thrombectomy use expanded. Absent procedural denominators, rates and causality cannot be inferred; findings support operator awareness, careful patient selection, and continued post-market surveillance.

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:Catheter‐Directed Interventional Devices for Pulmonary Embolism: A Maude Database Analysis of Adverse Events

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。